Exelon (EXC) Coveraged By UBS with $44.0 Target; Inogen (INGN) Sentiment Is 1.2

Inogen, Inc., a medical technology company, primarily develops, makes, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company has market cap of $2.51 billion. The companyÂ’s oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It has a 97.81 P/E ratio. It offers Inogen One systems, which are portable devices that concentrate the air around the patients to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories.

Among 21 analysts covering Exelon Corporation (NYSE:EXC), 13 have Buy rating, 2 Sell and 6 Hold. Therefore 62% are positive. Exelon Corporation has $50.0 highest and $27 lowest target. $39.97’s average target is 5.97% above currents $37.72 stock price. Exelon Corporation had 67 analyst reports since July 21, 2015 according to SRatingsIntel. Credit Suisse initiated the shares of EXC in report on Wednesday, January 25 with “Outperform” rating. Jefferies maintained the shares of EXC in report on Monday, October 10 with “Buy” rating. Barclays Capital initiated the shares of EXC in report on Thursday, March 24 with “Overweight” rating. The stock of Exelon Corporation (NYSE:EXC) earned “Buy” rating by Wells Fargo on Monday, August 31. SunTrust maintained the shares of EXC in report on Monday, January 8 with “Buy” rating. Guggenheim upgraded Exelon Corporation (NYSE:EXC) on Friday, September 25 to “Buy” rating. The stock has “Equal-Weight” rating by Morgan Stanley on Tuesday, March 28. Citigroup downgraded the shares of EXC in report on Tuesday, February 23 to “Sell” rating. The firm earned “Buy” rating on Monday, March 7 by Argus Research. SunTrust maintained Exelon Corporation (NYSE:EXC) rating on Wednesday, October 18. SunTrust has “Buy” rating and $43.0 target.

The stock decreased 0.32% or $0.12 during the last trading session, reaching $37.72. About 5.53M shares traded. Exelon Corporation (NYSE:EXC) has risen 2.57% since February 4, 2017 and is uptrending. It has underperformed by 14.13% the S&P500.

Since September 11, 2017, it had 0 insider buys, and 3 selling transactions for $24.20 million activity. Aliabadi Paymon had sold 13,333 shares worth $510,787. SHATTUCK MAYO A III had sold 567,070 shares worth $22.75M on Wednesday, October 25. Another trade for 25,000 shares valued at $936,000 was sold by Cornew Kenneth W..

Investors sentiment decreased to 1.05 in 2017 Q3. Its down 0.09, from 1.14 in 2017Q2. It fall, as 48 investors sold Exelon Corporation shares while 239 reduced holdings. 63 funds opened positions while 237 raised stakes. 726.69 million shares or 0.50% more from 723.10 million shares in 2017Q2 were reported. Citigroup reported 485,379 shares or 0.01% of all its holdings. Cliftonlarsonallen Wealth Advsr Ltd Liability Corp reported 0.19% in Exelon Corporation (NYSE:EXC). Webster Bank & Trust N A has invested 0.01% of its portfolio in Exelon Corporation (NYSE:EXC). The California-based Golub Group Incorporated Ltd Liability Company has invested 0.17% in Exelon Corporation (NYSE:EXC). Strs Ohio stated it has 748,694 shares. Lombard Odier Asset Management (Europe) Limited reported 0.02% of its portfolio in Exelon Corporation (NYSE:EXC). Guggenheim Capital Limited Liability Corporation invested 0.17% in Exelon Corporation (NYSE:EXC). Brown Advisory Ltd Liability Corporation holds 11,075 shares or 0.09% of its portfolio. Cushing Asset Management Lp holds 0.07% or 58,400 shares. Jfs Wealth Advisors Ltd Llc has invested 0.04% in Exelon Corporation (NYSE:EXC). Prelude Mngmt Limited Liability Corporation reported 0.02% of its portfolio in Exelon Corporation (NYSE:EXC). Sandy Spring Fincl Bank, Maryland-based fund reported 2,963 shares. Dreman Value Management L L C reported 45,594 shares stake. Vega Group Lc has 22.47% invested in Exelon Corporation (NYSE:EXC) for 450,100 shares. California Public Employees Retirement holds 2.91 million shares or 0.16% of its portfolio.

Exelon Corporation, a utility services holding company, engages in the energy generation and delivery businesses in the United States and Canada. The company has market cap of $36.24 billion. It owns electric generating facilities, such as nuclear, fossil, wind, hydroelectric, and solar generating facilities. It has a 16.88 P/E ratio. The firm also sells renewable energy and other energy-related services and products; and sells electricity and natural gas to wholesale and retail customers.

Analysts await Exelon Corporation (NYSE:EXC) to report earnings on February, 14. They expect $0.60 earnings per share, up 36.36% or $0.16 from last year’s $0.44 per share. EXC’s profit will be $576.51 million for 15.72 P/E if the $0.60 EPS becomes a reality. After $0.85 actual earnings per share reported by Exelon Corporation for the previous quarter, Wall Street now forecasts -29.41% negative EPS growth.

Analysts await Inogen, Inc. (NASDAQ:INGN) to report earnings on February, 27. They expect $0.21 earnings per share, down 16.00% or $0.04 from last year’s $0.25 per share. INGN’s profit will be $4.38M for 143.35 P/E if the $0.21 EPS becomes a reality. After $0.33 actual earnings per share reported by Inogen, Inc. for the previous quarter, Wall Street now forecasts -36.36% negative EPS growth.

The stock decreased 1.46% or $1.79 during the last trading session, reaching $120.41. About 58,132 shares traded. Inogen, Inc. (INGN) has risen 88.09% since February 4, 2017 and is uptrending. It has outperformed by 71.39% the S&P500.